A61K 38/1793
For cytokines
Official title: {for cytokines; for lymphokines; for interferons}
A61K38/1793 (For cytokines) appears on 735 US grants and 1,454 published applications in this corpus.
Search patents in A61K- Granted patents
- 735
- Published applications
- 1,454
- Assignees
- 625
- Inventors
- 2,256
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 5 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 6 | 8 |
| 2002 | 7 | 28 |
| 2003 | 11 | 32 |
| 2004 | 7 | 31 |
| 2005 | 4 | 34 |
| 2006 | 11 | 36 |
| 2007 | 9 | 35 |
| 2008 | 13 | 34 |
| 2009 | 13 | 44 |
| 2010 | 29 | 50 |
| 2011 | 26 | 43 |
| 2012 | 24 | 43 |
| 2013 | 21 | 50 |
| 2014 | 34 | 56 |
| 2015 | 23 | 64 |
| 2016 | 39 | 77 |
| 2017 | 50 | 67 |
| 2018 | 43 | 77 |
| 2019 | 56 | 98 |
| 2020 | 54 | 72 |
| 2021 | 52 | 98 |
| 2022 | 54 | 98 |
| 2023 | 34 | 78 |
| 2024 | 32 | 78 |
| 2025 | 42 | 73 |
| 2026 | 31 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of reducing neuroinflammation6 Oct 2026US 12,751,994 B2ImmunityBio, Inc.
- Anti-CD123 antibodies, anti-CD123 chimeric antigen receptors and anti-CD123 chimeric antigen receptors T cells29 Sep 2026US 12,747,295 B2Centre Hospitalier Regional Universitaire De Besancon
- Treatment of immunosuppressed subjects15 Sep 2026US 12,734,216 B2NantCell, Inc.
- Gene editing of monogenic disorders in human hematopoietic stem cells—correction of x-linked hyper-IGM syndrome (XHIM)15 Sep 2026US 12,735,720 B2The Regents of the University of California
- Methods and compositions comprising enhanced targeted immune gene therapy for the treatment of cancer18 Aug 2026US 12,708,653 B2Endeavor Health Clinical Operations
- Methods and Compositions for Treating Cancer24 Sep 2026US 2026/0284052 A1The United States Government as represented by the Department of Veterans Affairs
- Immune therapy and cancer24 Sep 2026US 2026/0284118 A1
- Engineered immune cells for treating cancer in combination with il-2/il-15 receptor beta-gamma agonists24 Sep 2026US 2026/0284145 A1Sotio Biotech Inc.
- Methods for the treatment of t-cell acute lymphoblastic leukemia24 Sep 2026US 2026/0284190 A1Centre National De La Recherche Scientifique
- Methods of treating alzheimer's disease17 Sep 2026US 2026/0274931 A1Klaritos, Inc.
Most cited
By later US patents
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Cytokine antagonists for the treatment of localized disorders163US 6,419,944 B22002
- Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease131US 6,270,766 B1The Kennedy Institute of Rheumatology · 2001
- Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra128US 8,124,084 B2University of Connecticut · 2012
- Methods of spray-drying a drug and a hydrophobic amino acid123US 6,372,258 B1Inhale Therapeutic Systems · 2002